Canopy Growth Corporation (WEED.TO)
CAD 1.64
(0.61%)
CAD 1.64
(0.61%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.3 Billion CAD | -46.69% |
| 2022 | 2.43 Billion CAD | -56.56% |
| 2021 | 5.61 Billion CAD | -17.71% |
| 2020 | 6.82 Billion CAD | -0.5% |
| 2019 | 6.85 Billion CAD | -21.46% |
| 2018 | 8.73 Billion CAD | 507.72% |
| 2017 | 1.43 Billion CAD | 112.04% |
| 2016 | 677.6 Million CAD | 372.66% |
| 2015 | 143.36 Million CAD | 452.19% |
| 2014 | 25.96 Million CAD | 403.78% |
| 2013 | 5.15 Million CAD | 914.83% |
| 2012 | 507.81 Thousand CAD | -6.88% |
| 2011 | 545.34 Thousand CAD | -3.17% |
| 2010 | 563.21 Thousand CAD | -4.26% |
| 2009 | 588.3 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 1.28 Billion CAD | -1.08% |
| 2023 Q3 | 1.35 Billion CAD | -18.49% |
| 2023 Q4 | 1.3 Billion CAD | -4.37% |
| 2023 FY | 1.3 Billion CAD | -46.69% |
| 2023 Q1 | 2.19 Billion CAD | -10.19% |
| 2023 Q2 | 1.66 Billion CAD | -23.84% |
| 2022 Q1 | 3.51 Billion CAD | -37.36% |
| 2022 Q2 | 3.4 Billion CAD | -3.28% |
| 2022 Q3 | 3.02 Billion CAD | -11.23% |
| 2022 FY | 2.43 Billion CAD | -56.56% |
| 2022 Q4 | 2.43 Billion CAD | -19.24% |
| 2021 Q3 | 6.3 Billion CAD | -2.8% |
| 2021 FY | 5.61 Billion CAD | -17.71% |
| 2021 Q4 | 5.61 Billion CAD | -11.0% |
| 2021 Q2 | 6.49 Billion CAD | -6.83% |
| 2021 Q1 | 6.96 Billion CAD | 2.1% |
| 2020 Q1 | 6.84 Billion CAD | -0.17% |
| 2020 Q2 | 6.57 Billion CAD | -3.97% |
| 2020 Q3 | 6.3 Billion CAD | -4.02% |
| 2020 FY | 6.82 Billion CAD | -0.5% |
| 2020 Q4 | 6.82 Billion CAD | 8.15% |
| 2019 Q2 | 8.22 Billion CAD | -4.86% |
| 2019 Q4 | 6.85 Billion CAD | -14.77% |
| 2019 Q3 | 8.04 Billion CAD | -2.18% |
| 2019 Q1 | 8.64 Billion CAD | -0.99% |
| 2019 FY | 6.85 Billion CAD | -21.46% |
| 2018 Q2 | 2.97 Billion CAD | 40.91% |
| 2018 FY | 8.73 Billion CAD | 507.72% |
| 2018 Q4 | 8.73 Billion CAD | 1.06% |
| 2018 Q3 | 8.64 Billion CAD | 190.28% |
| 2018 Q1 | 2.11 Billion CAD | 47.01% |
| 2017 FY | 1.43 Billion CAD | 112.04% |
| 2017 Q4 | 1.43 Billion CAD | 31.2% |
| 2017 Q3 | 1.09 Billion CAD | 37.12% |
| 2017 Q2 | 798.68 Million CAD | 7.4% |
| 2017 Q1 | 743.66 Million CAD | 9.75% |
| 2016 Q3 | 280.66 Million CAD | 43.05% |
| 2016 FY | 677.6 Million CAD | 372.66% |
| 2016 Q2 | 196.2 Million CAD | 28.88% |
| 2016 Q4 | 677.6 Million CAD | 141.43% |
| 2016 Q1 | 152.23 Million CAD | 6.19% |
| 2015 Q3 | 149.54 Million CAD | 20.78% |
| 2015 Q4 | 143.36 Million CAD | -4.14% |
| 2015 FY | 143.36 Million CAD | 452.19% |
| 2015 Q1 | 49.75 Million CAD | 4.15% |
| 2015 Q2 | 123.82 Million CAD | 148.86% |
| 2014 Q2 | 25.36 Million CAD | -8.31% |
| 2014 Q4 | 47.77 Million CAD | 84.01% |
| 2014 Q3 | 25.96 Million CAD | 2.36% |
| 2014 Q1 | 27.66 Million CAD | 91.17% |
| 2014 FY | 25.96 Million CAD | 403.78% |
| 2013 Q2 | 500.79 Thousand CAD | -1.38% |
| 2013 Q3 | 463.97 Thousand CAD | -7.35% |
| 2013 Q4 | 14.46 Million CAD | 3018.58% |
| 2013 FY | 5.15 Million CAD | 914.83% |
| 2013 Q1 | 507.81 Thousand CAD | -0.63% |
| 2012 Q2 | 532.69 Thousand CAD | -2.32% |
| 2012 Q4 | 511.05 Thousand CAD | -0.9% |
| 2012 Q3 | 515.69 Thousand CAD | -3.19% |
| 2012 Q1 | 545.34 Thousand CAD | 0.22% |
| 2012 FY | 507.81 Thousand CAD | -6.88% |
| 2011 FY | 545.34 Thousand CAD | -3.17% |
| 2011 Q4 | 544.13 Thousand CAD | -2.16% |
| 2011 Q3 | 556.14 Thousand CAD | -1.46% |
| 2011 Q2 | 564.39 Thousand CAD | 0.21% |
| 2011 Q1 | 563.21 Thousand CAD | 0.17% |
| 2010 Q1 | 588.3 Thousand CAD | 146.37% |
| 2010 FY | 563.21 Thousand CAD | -4.26% |
| 2010 Q4 | 562.22 Thousand CAD | -1.09% |
| 2010 Q3 | 568.42 Thousand CAD | -2.23% |
| 2010 Q2 | 581.39 Thousand CAD | -1.17% |
| 2009 Q4 | 238.78 Thousand CAD | 0.0% |
| 2009 FY | 588.3 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Aurora Cannabis Inc. | 838.67 Million CAD | -55.046% |
| Avicanna Inc. | 21.97 Million CAD | -5818.363% |
| Avant Brands Inc. | 82.55 Million CAD | -1475.165% |
| Cardiol Therapeutics Inc. | 36.7 Million CAD | -3443.084% |
| Crescita Therapeutics Inc. | 24.59 Million CAD | -5186.324% |
| Knight Therapeutics Inc. | 945.49 Million CAD | -37.529% |
| MediPharm Labs Corp. | 63.93 Million CAD | -1933.768% |
| OrganiGram Holdings Inc. | 298.45 Million CAD | -335.687% |
| Willow Biosciences Inc. | 6.67 Million CAD | -19386.438% |
| Auxly Cannabis Group Inc. | 261.9 Million CAD | -396.491% |